-
EP0528011
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0528011
| EP0528011 - CD4-GAMMA2 AND CD4-IgG2 CHIMERAS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.10.2003 Database last updated on 24.08.2024 | Most recent event Tooltip | 24.10.2003 | Application deemed to be withdrawn | published on 10.12.2003 [2003/50] | Applicant(s) | For all designated states PROGENICS PHARMACEUTICALS, INC. Old Saw Mill River Road P.O. Box 549 Tarrytown, NY 10591 / US | [N/P] |
| Former [1993/08] | For all designated states PROGENICS PHARMACEUTICALS, INC. Old Saw Mill River Road P.O. Box 549 Tarrytown, NY 10591 / US | Inventor(s) | 01 /
BEAUDRY, Gary, A. 109 Inwood Avenue Upper Montclair, NJ 07043 / US | 02 /
MADDON, Paul, J. 60 Haven Avenue Apt. 25C New York, NY 10032 / US | [1993/08] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [1993/08] | VOSSIUS & PARTNER Postfach 86 07 67 D-81634 München / DE | Application number, filing date | 92907272.6 | 10.02.1992 | [1993/08] | WO1992US01143 | Priority number, date | US19910653684 | 08.02.1991 Original published format: US 653684 | [1993/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9213947 | Date: | 20.08.1992 | Language: | EN | [1992/22] | Type: | A1 Application with search report | No.: | EP0528011 | Date: | 24.02.1993 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.08.1992 takes the place of the publication of the European patent application. | [1993/08] | Search report(s) | International search report - published on: | US | 20.08.1992 | (Supplementary) European search report - dispatched on: | EP | 11.05.1993 | Classification | IPC: | C12N15/62, C07K13/00, A61K39/00, G01N33/533, G01N33/534 | [1993/24] | CPC: |
C07K14/70514 (EP,US);
A61K47/6875 (EP,US);
C07K16/00 (EP,US);
A61K38/00 (EP,US);
C07K2319/00 (EP,US);
C07K2319/30 (EP,US)
|
| Former IPC [1993/08] | C12N15/00, A61K39/00, C07K13/00 | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, MC, NL, SE [1993/08] | Title | German: | CD4-GAMMA2 UND CD4-IGG2 CHIMÄREN | [1993/08] | English: | CD4-GAMMA2 AND CD4-IgG2 CHIMERAS | [1993/08] | French: | CHIMERES DE CD4-GAMMA2 ET DE CD4-IgG2 | [1993/08] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 09.11.1992 | National basic fee paid | 09.11.1992 | Search fee paid | 09.11.1992 | Designation fee(s) paid | 22.02.1993 | Examination fee paid | Examination procedure | 22.02.1993 | Examination requested [1993/16] | 12.12.1996 | Despatch of a communication from the examining division (Time limit: M04) | 22.04.1997 | Reply to a communication from the examining division | 11.07.1997 | Despatch of a communication from the examining division (Time limit: M06) | 21.01.1998 | Reply to a communication from the examining division | 11.08.1998 | Despatch of a communication from the examining division (Time limit: M06) | 04.06.1999 | Reply to a communication from the examining division | 30.07.2002 | Despatch of a communication from the examining division (Time limit: M06) | 10.02.2003 | Reply to a communication from the examining division | 27.03.2003 | Despatch of a communication from the examining division (Time limit: M02) | 07.06.2003 | Application deemed to be withdrawn, date of legal effect [2003/50] | 11.07.2003 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2003/50] | Divisional application(s) | EP03012917.5 / EP1340769 | Request for further processing for: | 04.06.1999 | Request for further processing filed | 04.06.1999 | Full payment received (date of receipt of payment) Request granted | 21.06.1999 | Decision despatched | Fees paid | Renewal fee | 17.01.1994 | Renewal fee patent year 03 | 19.01.1995 | Renewal fee patent year 04 | 16.01.1996 | Renewal fee patent year 05 | 15.01.1997 | Renewal fee patent year 06 | 20.05.1998 | Renewal fee patent year 07 | 15.01.1999 | Renewal fee patent year 08 | 19.01.2000 | Renewal fee patent year 09 | 19.01.2001 | Renewal fee patent year 10 | 21.01.2002 | Renewal fee patent year 11 | 20.01.2003 | Renewal fee patent year 12 | Penalty fee | Additional fee for renewal fee | 28.02.1998 | 07 M06 Fee paid on 20.05.1998 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E]WO9213559 (PROGENICS PHARM INC [US]) | [X] - BIOCHEMISTRY. vol. 29, no. 42, 23 October 1990, EASTON, PA US pages 9885 - 9891 Chamow SM;Peers DH;Byrn RA;Mulkerrin MG;Harris RJ;Wang WC;Bjorkman PJ;Capon DJ;Ashkenazi A; 'Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments.' | [X] - DNA AND CELL BIOLOGY vol. 9, no. 5, June 1990, NEW YORK US pages 347 - 353 Zettlmeissl G;Gregersen JP;Duport JM;Mehdi S;Reiner G;Seed B; 'Expression and characterization of human CD4:immunoglobulin fusion proteins.' | International search | [Y]US4664911 (UHR JONATHAN W [US], et al); | [Y]WO8902922 (GENENTECH INC [US]); | [Y]WO8906690 (GEN HOSPITAL CORP [US]); | [Y]WO9001035 (US COMMERCE [US]); | [Y]JPH02107393 (ASAHI CHEMICAL IND); | [Y]WO9100360 (MEDAREX INC [US]) | [YP] - Science, Volume 254, issued 22 November 1991, I. PASTAN et al., "Recombinant Toxins for Cancer Treatment", pages 1173-1177, see entire document. | [Y] - J. Biological Chemistry, Volume 264, No. 26, issued 15 September 1989, I. PASTAN et al., "Pseudomonas exotoxin: chimeric toxins", pages 15157-15160, see especially page 15159, paragraphs 2-3. | [Y] - Science, Volume 242, issued 25 November 1988, M.A. TILL et al., "HIV-Infected cells are killed by rCD4-Ricin A Chain", pages 1166-1168, see especially Abstract. | [Y] - Proc. Nat. Acad. Sci. US, Volume 81, issued November 1984, S.L. MORRISON et al., "Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains", pages 6851-6855, see entire article. | [Y] - Nature, Volume 339, issued 04 May 1989, A. TRAUNECKER et al., "Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules", pages 68-70, see entire article, especially Abstract. | [Y] - Nature, Volume 344, issued 12 April 1990, R.A. BYRN et al., "Biological properties of a CD4 immunoadhesin", pages 667-670, see entire article, especially page 667, 1st paragraph following Abstract. | [Y] - Nature, Volume 337, issued 09 February 1989, D.J. CAPON et al., "Designing CD4 immunoadhesins for AIDS therapy", pages 525-531, see especially paragraph bridging pages 525-526, last paragraph of column 1, page 530. | [Y] - Cancer Research, Volume 45, issued May 1985, J.L. MURRAY et al., "Radioimaging in malignant melanoma with 111In-labelled monoclonal antibody 96.5", pages 2376-2381, see entire document. | [Y] - DNA and Cell Biology, Volume 9, No. 5, issued 1990, G. ZEITMEISSL et al., "Expression and characterization of human CD4: immunoglobulin fusion proteins", pages 347-353, see entire article. | [X] - Microbiol. Immunol., Volume 180, No. 4, issued 1991, CHOWDHURY et al., "Evaluation of anti-human immunodeficiency virus effect of recombinant CD4-immunoglobulin in-vitro a good candidate for AIDS treatment", pages 183-192, see Abstract No. 92129982. |